Alpha-1-antichymotrypsin Promotes Beta-sheet Amyloid Plaque Deposition in a Transgenic Mouse Model of Alzheimer's Disease

Overview

Journal J Neurosci

Specialty Neurology

Date 2001 Feb 27

PMID 11222634

Citations 47

Authors

L N Nilsson

K R Bales

G DICARLO

M N Gordon

D Morgan

S M Paul

H Potter

Affiliations

Soon will be listed here.

Abstract

Alpha(1)-antichymotrypsin (ACT), an acute-phase inflammatory protein, is an integral component of the amyloid deposits in Alzheimer's disease (AD) and has been shown to catalyze amyloid beta-peptide polymerization in vitro. We have investigated the impact of ACT on amyloid deposition in vivo by generating transgenic GFAP-ACT-expressing mice and crossing them with the PDGF-hAPP/V717F mice, which deposit amyloid in an age-dependent manner. The number of amyloid deposits measured by Congo Red birefringence was increased in the double ACT/amyloid precursor protein (APP) transgenic mice compared with transgenic mice that only expressed APP, particularly in the hippocampus where ACT expression was highest, and the increase was preceded by elevated total amyloid beta-peptide levels at an early age. Our data demonstrate that ACT promotes amyloid deposition and provide a specific mechanism by which inflammation and the subsequent upregulation of astrocytic ACT expression in AD brain contributes to AD pathogenesis.

Citing Articles

Single Cell Deletion of the Transcription Factors Trps1 and Sox9 in Astrocytes Reveals Novel Functions in the Adult Cerebral Cortex.

Natarajan P, Koupourtidou C, de Resseguier T, Thorwirth M, Bocchi R, Fischer-Sternjak J Glia. 2024; 73(4):737-758.

PMID: 39610085 PMC: 11845849. DOI: 10.1002/glia.24645.

Sex-Specific Impact of Fkbp5 on Hippocampal Response to Acute Alcohol Injection: Involvement in Alterations of Metabolism-Related Pathways.

Williams K, Zou Y, Qiu B, Kono T, Guo C, Garcia D Cells. 2024; 13(1).

PMID: 38201293 PMC: 10778370. DOI: 10.3390/cells13010089.

Plasma Exchange Reduces Aβ Levels in Plasma and Decreases Amyloid Plaques in the Brain in a Mouse Model of Alzheimer's Disease.

Ramirez S, Koerich S, Astudillo N, De Gregorio N, Al-Lahham R, Allison T Int J Mol Sci. 2023; 24(23).

PMID: 38069410 PMC: 10706894. DOI: 10.3390/ijms242317087.

Amyloids and brain cancer: molecular linkages and crossovers.

Singh S, Joshi V, Upadhyay A Biosci Rep. 2023; 43(10).

PMID: 37335084 PMC: 10548166. DOI: 10.1042/BSR20230489.

The Functions and Phenotypes of Microglia in Alzheimer's Disease.

Fujikawa R, Tsuda M Cells. 2023; 12(8).

PMID: 37190116 PMC: 10136897. DOI: 10.3390/cells12081207.

References

Sanan D, Weisgraber K, Russell S, Mahley R, Huang D, Saunders A . Apolipoprotein E associates with beta amyloid peptide of Alzheimer's disease to form novel monofibrils. Isoform apoE4 associates more efficiently than apoE3. J Clin Invest. 1994; 94(2):860-9. PMC: 296168. DOI: 10.1172/JCI117407. View

Rogers J, Leiter L, McPhee J, Cahill C, Zhan S, Potter H . Translation of the alzheimer amyloid precursor protein mRNA is up-regulated by interleukin-1 through 5'-untranslated region sequences. J Biol Chem. 1999; 274(10):6421-31. DOI: 10.1074/jbc.274.10.6421. View

Hwang S, Steineckert B, Kohn A, Palkovits M, Hook V . Molecular studies define the primary structure of alpha1-antichymotrypsin (ACT) protease inhibitor in Alzheimer's disease brains. Comparison of act in hippocampus and liver. J Biol Chem. 1999; 274(3):1821-7. DOI: 10.1074/jbc.274.3.1821. View

Hyman B, West H, Rebeck G, Buldyrev S, Mantegna R, Ukleja M . Quantitative analysis of senile plaques in Alzheimer disease: observation of log-normal size distribution and molecular epidemiology of differences associated with apolipoprotein E genotype and trisomy 21 (Down syndrome). Proc Natl Acad Sci U S A. 1995; 92(8):3586-90. PMC: 42212. DOI: 10.1073/pnas.92.8.3586. View

Nicoll J, Mrak R, Graham D, Stewart J, Wilcock G, MacGowan S . Association of interleukin-1 gene polymorphisms with Alzheimer's disease. Ann Neurol. 2000; 47(3):365-8. PMC: 3833599. View

Ma J, Yee A, BREWER Jr H, Das S, Potter H . Amyloid-associated proteins alpha 1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer beta-protein into filaments. Nature. 1994; 372(6501):92-4. DOI: 10.1038/372092a0. View

Eriksson S, Janciauskiene S, Lannfelt L . Alpha 1-antichymotrypsin regulates Alzheimer beta-amyloid peptide fibril formation. Proc Natl Acad Sci U S A. 1995; 92(6):2313-7. PMC: 42805. DOI: 10.1073/pnas.92.6.2313. View

Hughes S, Khorkova O, Goyal S, Knaeblein J, Heroux J, Riedel N . Alpha2-macroglobulin associates with beta-amyloid peptide and prevents fibril formation. Proc Natl Acad Sci U S A. 1998; 95(6):3275-80. PMC: 19732. DOI: 10.1073/pnas.95.6.3275. View

Sheng J, Mrak R, Griffin W . Microglial interleukin-1 alpha expression in brain regions in Alzheimer's disease: correlation with neuritic plaque distribution. Neuropathol Appl Neurobiol. 1995; 21(4):290-301. DOI: 10.1111/j.1365-2990.1995.tb01063.x. View

10.

Hill R, Hastie N . Accelerated evolution in the reactive centre regions of serine protease inhibitors. Nature. 1987; 326(6108):96-9. DOI: 10.1038/326096a0. View

11.

Potter H, Nelson R, Das S, Siman R, Kayyali U, Dressler D . The involvement of proteases, protease inhibitors, and an acute phase response in Alzheimer's disease. Ann N Y Acad Sci. 1992; 674:161-73. DOI: 10.1111/j.1749-6632.1992.tb27485.x. View

12.

Evans K, Berger E, Cho C, Weisgraber K, Lansbury Jr P . Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: implications for the pathogenesis and treatment of Alzheimer disease. Proc Natl Acad Sci U S A. 1995; 92(3):763-7. PMC: 42700. DOI: 10.1073/pnas.92.3.763. View

13.

Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole G . Inflammation and Alzheimer's disease. Neurobiol Aging. 2000; 21(3):383-421. PMC: 3887148. DOI: 10.1016/s0197-4580(00)00124-x. View

14.

Mucke L, Yu G, McConlogue L, Rockenstein E, Abraham C, Masliah E . Astroglial expression of human alpha(1)-antichymotrypsin enhances alzheimer-like pathology in amyloid protein precursor transgenic mice. Am J Pathol. 2000; 157(6):2003-10. PMC: 1885780. DOI: 10.1016/s0002-9440(10)64839-0. View

15.

Abraham C, Shirahama T, Potter H . Alpha 1-antichymotrypsin is associated solely with amyloid deposits containing the beta-protein. Amyloid and cell localization of alpha 1-antichymotrypsin. Neurobiol Aging. 1990; 11(2):123-9. DOI: 10.1016/0197-4580(90)90045-2. View

16.

Abraham C, Selkoe D, Potter H . Immunochemical identification of the serine protease inhibitor alpha 1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease. Cell. 1988; 52(4):487-501. DOI: 10.1016/0092-8674(88)90462-x. View

17.

Sarid J . Identification of a cis-acting positive regulatory element of the glial fibrillary acidic protein gene. J Neurosci Res. 1991; 28(2):217-28. DOI: 10.1002/jnr.490280209. View

18.

Diedrich J, Minnigan H, Carp R, Whitaker J, Race R, Frey 2nd W . Neuropathological changes in scrapie and Alzheimer's disease are associated with increased expression of apolipoprotein E and cathepsin D in astrocytes. J Virol. 1991; 65(9):4759-68. PMC: 248933. DOI: 10.1128/JVI.65.9.4759-4768.1991. View

19.

Janciauskiene S, Rubin H, Lukacs C, Wright H . Alzheimer's peptide Abeta1-42 binds to two beta-sheets of alpha1-antichymotrypsin and transforms it from inhibitor to substrate. J Biol Chem. 1998; 273(43):28360-4. DOI: 10.1074/jbc.273.43.28360. View

20.

Bales K, Verina T, Dodel R, Du Y, Altstiel L, Bender M . Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition. Nat Genet. 1997; 17(3):263-4. DOI: 10.1038/ng1197-263. View